11.01.2021 • News

Moderna Appoints Chief Commercial Officer

As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort. Corinne Le Goff will take up the position on Jan. 19.

Le Goff’s last role was senior vice president of Amgen and president of its US business. The pharmacist by training is credited with overseeing Amgen’s Otezla integration after the company acquired the drug from Celgene in 2019, along with boosting sales of cholesterol med Repatha and migraine launch Aimovig.

“Corinne is joining us at an important time as we launch our Covid-19 vaccine, prepare to start the Phase 3 study of our CMV vaccine and pivot to a commercial-stage company,” Moderna CEO Stéphane Bancel said in a statement.

Author: Dede Williams, Freelance Journalist

As it rolls out an increasing number of doses of its mRNA-based Covid-19... — As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort. Corinne Le Goff will take up the position on Jan. 19. (c) JULIE BOURGES

Article

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

From Catalogue to Collaboration

Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.